Explore the Global Brain Cancer Diagnostics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Brain Cancer Diagnostics Market

Key Insight

Brain cancer diagnostics sales will rise through 2036, driven by magnetic resonance spectroscopy at 34.5% of the test type segment in 2026, supported by sustained demand from core end-use applications. The market was valued at USD 5.73 billion in 2025 and is expected to be worth USD 18.45 billion by 2036.

May 13, 2026

Anurag Sharma

250 Pages

Cite this Report

Brain Cancer Diagnostics Market

https://www.futuremarketinsights.com/reports/brain-cancer-diagnostics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott Laboratories
Agilent Technologies
Canon Medical Systems Corporation
F. Hoffmann-La Roche Ag
T. Rowe Price
Illumina
Koninklijke Philips NV
QIAGEN N.V
Siemens
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Brain Cancer Diagnostics Market

Key Players

Similar Industry Reports